APR 1, 202665 MINS READ
The foundation of high-performance silicone rubber tube lies in the precise control of organopolysiloxane chemistry and crosslinking architecture. Modern silicone rubber tube formulations are based on platinum-catalyzed addition-cure systems that combine vinyl-functional organopolysiloxanes with organohydrogenpolysiloxanes to achieve tailored mechanical properties246. The vinyl group-containing organopolysiloxane (Component A) typically exhibits vinyl content in the range of 0.10–0.50 mol%, which directly influences crosslink density and final elastomer modulus17. Linear organopolysiloxanes (A1) provide baseline flexibility and processability, while branched organopolysiloxanes (A2) contribute to enhanced tear strength and dimensional stability16. The organohydrogenpolysiloxane (Component B) serves as the crosslinker, with Si-H group content ranging from 0.18–1.6 mol% and molar ratios of Si-H to vinyl groups optimized between 0.5:1 and 4:1 to balance cure kinetics with mechanical performance17.
Reinforcing silica particles (Component C) are incorporated at loadings of 20–80 parts per hundred rubber (phr) to enhance tensile strength and tear resistance17. Surface treatment of silica with silane coupling agents (Component D) is critical for achieving optimal filler-matrix interaction. Trimethylsilyl-functional silane coupling agents have demonstrated superior performance in promoting high hardness, high modulus, and excellent restorability (rubber elasticity)47. Alternative coupling agents bearing methacryloxy groups have also shown efficacy when applied at 0.1–15 phr and thermally activated at 50–200°C for 5 minutes to 24 hours8. Platinum or platinum compounds (Component E) catalyze the hydrosilylation reaction at concentrations as low as 0.000002–0.00005 parts, enabling rapid cure at elevated temperatures while maintaining pot life at ambient conditions17.
The resulting cured silicone rubber exhibits Type A durometer hardness in the range of 30–55 Shore A, tensile strength of 7–15 MPa, tear strength of 30–60 N/mm, and tensile permanent set below 9.0%41419. These properties position silicone rubber tube as a material of choice for applications demanding both flexibility and mechanical integrity.
A significant advancement in silicone rubber tube formulation involves the incorporation of both linear and branched organopolysiloxanes within the vinyl-functional component (A)16. This dual-phase approach addresses the inherent trade-off between flexibility and mechanical strength. Linear organopolysiloxanes (A1) contribute to high elongation at break (typically >400%) and low compression set, while branched organopolysiloxanes (A2) enhance tear propagation resistance and reduce stress concentration at defect sites1115. Formulations satisfying Requirement X (containing both A1 and A2) have demonstrated tensile strengths exceeding 10 MPa and tear strengths above 40 N/mm, representing a 25–35% improvement over single-phase systems16.
Similarly, the organohydrogenpolysiloxane crosslinker (B) can be optimized through blending linear (B1) and branched (B2) architectures511. Linear organohydrogenpolysiloxanes provide uniform crosslink distribution and predictable cure kinetics, whereas branched variants introduce multifunctional crosslink nodes that enhance network connectivity and reduce chain slippage under load6. Formulations meeting Requirement Y (containing mixtures B3 of B1 and B2, or solely B2) exhibit improved resistance to kinking and shredding—critical failure modes in medical catheter applications1516. The molar ratio of branched to linear organohydrogenpolysiloxane is typically maintained between 1:3 and 3:1 to balance processability with final mechanical properties11.
The choice of silane coupling agent profoundly influences the mechanical performance of silicone rubber tube. Trimethylsilyl-functional silanes (e.g., hexamethyldisilazane derivatives) promote hydrophobic silica surfaces that exhibit minimal moisture sensitivity and excellent compatibility with the siloxane matrix7. Surface-treated silica prepared with these agents at 2–10 phr loading yields silicone rubbers with tensile strengths of 8.5–12 MPa and tear strengths of 35–50 N/mm47. The treatment process involves dry-mixing silica with the silane coupling agent followed by thermal activation at 100–150°C for 1–4 hours under inert atmosphere to ensure complete surface functionalization8.
Methacryloxy-functional silanes represent an alternative approach, offering reactive sites that can participate in secondary crosslinking reactions during cure8. When applied at 0.5–5 phr and activated at 120–180°C for 30 minutes to 2 hours, these agents produce silicone rubbers with enhanced abrasion resistance (Taber Abrasion test values <500 mg at 3000 cycles with 1000-g load and H-18 wheels) and improved resistance to shredding during catheter insertion14. The optimal silane loading and activation conditions must be tailored to the specific silica surface area (typically 150–350 m²/g for fumed silica) and the desired balance between reinforcement and processability8.
Platinum-based catalysts enable room-temperature stability combined with rapid high-temperature cure, a critical requirement for continuous extrusion processes used in silicone rubber tube manufacturing26. Karstedt's catalyst (platinum-divinyltetramethyldisiloxane complex) is the most widely employed system, with platinum concentrations ranging from 2 to 50 ppm (0.000002–0.00005 parts by weight)17. Cure inhibitors such as ethynylcyclohexanol or methylvinylcyclotetrasiloxane are added at 0.01–0.5 phr to extend pot life to 4–24 hours at 25°C while maintaining cure times of 1–10 minutes at 120–180°C611.
The hydrosilylation reaction kinetics are influenced by the vinyl-to-Si-H molar ratio, with stoichiometric ratios (1:1) providing maximum crosslink density but limited elongation, while excess vinyl (Si-H:vinyl = 0.5:1 to 0.8:1) yields more flexible networks with improved fatigue resistance17. Post-cure thermal treatment at 150–200°C for 2–4 hours is often employed to complete residual crosslinking reactions and volatilize low-molecular-weight cyclic siloxanes, thereby reducing extractables and improving biocompatibility for medical applications215.
Silicone rubber tubes are predominantly manufactured via continuous extrusion through annular dies, with die dimensions selected to achieve target inner diameters (ID) of 1–10 mm and outer diameters (OD) of 2–34 French (0.67–11.3 mm)1214. Single-layer tubes are extruded from homogeneous curable compositions, whereas multi-layer structures employ co-extrusion to combine distinct silicone formulations with complementary properties14. For example, a dual-layer medical catheter may feature an outer layer optimized for tear strength (30–60 N/mm) and a low-friction inner layer with enhanced abrasion resistance (<500 mg Taber loss)14. The graduated mixture zone between layers is controlled by adjusting extrusion temperatures (80–140°C) and flow rates to achieve interfacial adhesion without discrete boundaries14.
Specialized extrusion dies incorporating arc-shaped connecting blocks enable the production of self-coiling silicone rubber tubes, which automatically roll into circular configurations upon exiting the die10. This geometry is advantageous for storage and handling in medical and industrial applications. Adjustable die cores with pneumatic or mechanical actuation allow real-time control of tube wall thickness (0.3–2.0 mm) and lumen diameter during extrusion, ensuring dimensional consistency across production runs10.
Following extrusion, silicone rubber tubes undergo primary vulcanization in continuous hot-air or infrared ovens at 150–200°C with residence times of 2–15 minutes, depending on wall thickness and formulation reactivity26. Incomplete cure results in excessive compression set (>10%) and poor dimensional stability, while over-cure leads to embrittlement and reduced elongation at break19. Pulse NMR analysis of spin-spin relaxation time (T₂) provides a non-destructive method for assessing cure state, with fully cured silicone rubbers exhibiting bimodal T₂ distributions corresponding to rigid crosslinked domains (T₂ = 0.1–1 ms) and mobile chain segments (T₂ = 5–20 ms)9.
Post-cure thermal treatment at 180–220°C for 2–6 hours in forced-air ovens or autoclaves serves multiple functions: completion of residual crosslinking reactions, volatilization of low-molecular-weight siloxanes and catalyst residues, and stress relaxation to minimize dimensional drift during service1517. For medical-grade silicone rubber tubes, post-cure is followed by extraction in solvents (e.g., hexane, isopropanol) or supercritical CO₂ to remove extractables to levels below 1.0 wt%, ensuring compliance with ISO 10993 biocompatibility standards217.
Silicone rubber tube manufacturing requires stringent dimensional control to ensure compatibility with medical devices (e.g., peristaltic pumps, catheter introducers) and industrial fittings13. Inner diameter tolerances are typically maintained within ±0.05–0.15 mm for tubes with ID <5 mm, and ±0.10–0.30 mm for larger diameters12. Outer diameter tolerances follow similar specifications, with wall thickness uniformity monitored via optical or ultrasonic measurement systems during extrusion10.
Mechanical property verification includes tensile testing per ASTM D412 (tensile strength, elongation at break, 100% modulus), tear testing per ASTM D624 (Die C tear strength), compression set per ASTM D395 (Method B, 22 hours at 70°C or 100°C), and durometer hardness per ASTM D2240 (Type A)41419. For medical applications, additional tests include biocompatibility screening (ISO 10993 series), gas permeability measurement (ASTM D1434), and extractables/leachables analysis via GC-MS and LC-MS12. Acceptance criteria are formulation-specific but generally require tensile strength ≥7 MPa, tear strength ≥30 N/mm, compression set ≤9%, and hardness 30–55 Shore A for catheter-grade silicone rubber tubes19.
Silicone rubber tubes are extensively employed in medical catheters due to their biocompatibility, flexibility, and resistance to kinking2415. Drainage catheters for post-surgical fluid removal (blood, pus, exudate) require tear strengths of 35–50 N/mm to withstand handling and insertion forces, combined with tensile elongations exceeding 400% to accommodate patient movement without tube rupture16. Percutaneous endoscopic gastrostomy (PEG) tubes for enteral nutrition demand transparency (light transmission >85% at 550 nm for 1-mm wall thickness) to enable visual inspection of fluid flow, alongside Shore A hardness of 40–50 to balance insertion ease with structural integrity615.
Urinary catheters benefit from low-friction inner surfaces to minimize urethral trauma during insertion and removal14. Co-extruded silicone rubber tubes with abrasion-resistant inner layers (Taber loss <400 mg) and tear-resistant outer layers (tear strength >40 N/mm) address these dual requirements14. The graduated mixture zone between layers ensures mechanical continuity and prevents delamination during flexure14. Silicone rubber tubes for cardiac lead insulation require outer diameters of 3–8 French and wall thicknesses of 0.2–0.5 mm, with tensile strengths exceeding 8 MPa and compression sets below 8% to maintain electrical isolation over 10–15 year service lifetimes14.
Peristaltic pumps for intravenous (IV) fluid delivery rely on silicone rubber tubes that undergo repetitive compression by rotating rollers, necessitating exceptional fatigue resistance and dimensional stability13. Tubes for peristaltic applications are typically manufactured with Shore A hardness of 50–60 to provide sufficient stiffness for occlusion while maintaining flexibility for roller engagement13. Wall thickness uniformity within ±0.05 mm is critical to ensure consistent flow rates (±5% over 24-hour operation) and prevent premature tube failure due to localized stress concentration13.
Fatigue testing per ASTM D430 (De Mattia flex test) or custom peristaltic cycling protocols (1–10 million cycles at 60–200 rpm) is employed to validate tube durability13. High-performance formulations incorporating branched organopolysiloxanes and optimized silica reinforcement achieve fatigue lifetimes exceeding 5 million cycles without visible cracking or flow rate degradation1116. Gas permeability is a secondary concern for IV applications, as oxygen and carbon dioxide diffusion through silicone rubber tube walls can alter fluid composition during prolonged infusion1. Barrier coatings (e.g., polyamide, EVOH) applied via co-extrusion or post-extrusion lamination reduce oxygen transmission rates from 15,000–20,000 cm³/(m²·day·atm) for uncoated silicone to <500 cm³/(m²·day·atm), extending fluid stability and reducing oxidative degradation of sensitive pharmaceuticals1.
Silicone rubber tubes serve as reservoir components in implantable drug delivery systems, where controlled permeation of active pharmaceutical ingredients (APIs) through the tube wall enables sustained therapeutic release over weeks to months17. The drug release rate is governed by Fick's first law of diffusion and depends on silicone rubber composition (crosslink density, filler content), tube wall thickness, and API physicochemical properties (molecular weight, lipophilicity)17. Formulations with vinyl content of 0.10–0.25 mol% and Si-H:vinyl ratios of 1.5:1 to 2.5:1 yield moderately crosslinked networks (swelling ratio in toluene = 4–6) that balance mechanical integrity with API diffusivity17.
Biocompatibility testing per ISO 10993-1 (cytotoxicity), ISO 10993-5 (sensitization), ISO 10993-10 (irritation), and ISO 10993-11 (systemic toxicity) confirms the suitability of silicone rubber tubes for long-term implantation17. Extractables levels below 0.5 wt% and residual platinum concentrations below 10 ppm are typical acceptance criteria17. Drug release kinetics are characterized via in vitro dissolution testing in simulated physiological fluids (pH 7.4, 37°C), with zero-order release profiles (constant release rate over time) achieved through optimization of tube geometry and silicone formulation17. Clinical applications include contraceptive implants (levonorgestrel
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| CAREFUSION 303 INC. | Peristaltic IV pump systems requiring controlled fluid delivery with minimal gas diffusion for prolonged pharmaceutical infusion and sensitive drug stability maintenance | IV Set with Low Permeability Silicone Rubber Tubing | Coated with gas barrier material layer, achieving low gas permeability while maintaining resilience, reducing oxygen transmission rates from 15,000-20,000 cm³/(m²·day·atm) to below 500 cm³/(m²·day·atm) |
| SUMITOMO BAKELITE CO. LTD. | Medical catheters including drainage tubes, percutaneous endoscopic gastrostomy (PEG) tubes, urinary catheters, and cardiac lead insulation requiring flexibility, kink resistance, and long-term biocompatibility in body contact applications | Medical Grade Silicone Rubber Catheter Tubing | Platinum-catalyzed addition-cure system with optimized vinyl-functional organopolysiloxanes and silica reinforcement, achieving tensile strength of 8-15 MPa, tear strength of 30-60 N/mm, and compression set below 9%, with enhanced biocompatibility meeting ISO 10993 standards |
| ST. JUDE MEDICAL AB | Implantable medical catheters and cardiac leads with outer diameter 3-34 French, requiring superior mechanical integrity, low-friction inner surfaces for minimized tissue trauma, and resistance to kinking and shredding during insertion procedures | Co-Extruded Dual-Layer Silicone Rubber Medical Catheter | Multi-layer structure with outer layer optimized for tear strength (30-60 N/mm) and inner layer with enhanced abrasion resistance (Taber loss <500 mg at 3000 cycles), featuring graduated mixture zone for interfacial adhesion without discrete boundaries |
| SHENYANG XINGHUA PHARMACEUTICAL TECHNOLOGY CO. LTD | Implantable drug delivery systems and contraceptive implants requiring long-term controlled pharmaceutical release over weeks to months through silicone matrix diffusion in subcutaneous or intracavitary environments | Silicone Tube for Implantable Drug Delivery System | Controlled crosslink density with vinyl content 0.10-0.50 mol% and Si-H:vinyl ratios 0.5:1 to 4:1, enabling sustained drug release through controlled permeation with zero-order release kinetics, extractables below 0.5 wt%, and residual platinum below 10 ppm for biocompatibility |
| SANKICONSYS CO. LTD. | Cooling garment fluid delivery networks requiring flexible tubing that accommodates textile movement, maintains consistent water flow through micropores, and prevents clogging issues common in synthetic resin hollow fiber membranes | Silicone Rubber Tube for Cooling Garment Fluid Delivery | Hardness 45-55 Shore A with inner diameter 1-2 mm and outer diameter 2-4 mm, featuring micropores 0.1-0.3 mm diameter for controlled fluid seepage, with elasticity matching clothing expansion/contraction to prevent breakage and clogging |